Avrohn Pharma (I) Limited - Company Profile

It is a pharma public limited company based in Delhi, Delhi, India, established in 2012.
2012 Delhi, Delhi, India Active
Last Updated:
Access Report
About Avrohn Pharma (I) Limited

Avrohn Pharma (I) Limited, a active public limited company, was established on 12 March 2012 in Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24119DL2012PLC232680. Registered under ROC Roc Delhi I. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.

It upholds a compliant status. Its leadership includes Neeta Verender Kumar Gupta (Director), Virender Kumar Gupta (Director), Abhishek Gupta (Director). Past directors included Garima Jain. It holds ₹3.37 Cr open charges and ₹6.00 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at G-216, Hall No. 1, Ground Floor, Dakka Village, Near Kingsway Camp,, Delhi, Delhi, 110009.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24119DL2012PLC232680

  • Registration Number

    232680

  • Incorporation Date

    12 March 2012

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Delhi I

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 13 Year, 11 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 3.37 Cr
  • Satisfied Charges ₹ 6.00 M
  • Revenue Growth **** 32.98%
  • Profit Growth **** 5.88%
  • Ebitda **** -9.11%
  • Net Worth 32.87%
  • Total Assets **** 22.75%
Company report

Avrohn Pharma (I) Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Avrohn Pharma (I) Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Avrohn Pharma (I) Limited?
Current Directors
Name Designation Appointment Date Status
Neeta Verender Kumar Gupta Director 26 Mar 2022 Current
Virender Kumar Gupta Director 12 Mar 2012 Current
Abhishek Gupta Director 12 Mar 2012 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 26 Mar 2022 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Avrohn Pharma (I).

Avrohn Pharma (I) Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 32.98% increase. The company also saw a slight improvement in profitability, with a 5.88% increase in profit. The company's net worth Soared by an impressive increase of 32.87%.

Avrohn Pharma (I) revenue growth over time
Avrohn Pharma (I) profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 32.98%
*******
*******
*******
*******
Revenue from Operations
*******
 32.98%
*******
*******
*******
*******
Total Assets
*******
 22.75%
*******
*******
*******
*******
Profit or Loss
*******
 5.88%
*******
*******
*******
*******
Net Worth
*******
 32.87%
*******
*******
*******
*******
EBITDA
*******
 -9.11%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Avrohn Pharma (I)?

In 2022, Avrohn Pharma (I) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹33,727,000.00

Satisfied Charges

₹6,000,000.00

Charges Breakdown by Lending Institutions
  • Canara Bank : 2.77 Cr
  • Others : 0.60 Cr
Latest Charge Details
Date Lender Amount Status
15 Nov 2025 Others ₹3.50 M Open
17 Jun 2025 Others ₹2.50 M Open
11 Mar 2025 Canara Bank ₹2.93 M Open
06 Feb 2024 Canara Bank ₹1.90 M Open
06 Nov 2023 Canara Bank ₹1.95 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Avrohn Pharma (I)?

Unlock and access historical data on people associated with Avrohn Pharma (I), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Avrohn Pharma (I), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avrohn Pharma (I)'s trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Avrohn Pharma (I)
Recent Activity within the Organization
  • Charges

    Progress on A charge with Others amounted to Rs. 3.50 M with Charge ID 101240020 was registered on 15 Nov 2025. was documented.

  • Annual General Meeting

    Avrohn Pharma (I) Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Charges

    A charge with Others amounted to Rs. 2.50 M with Charge ID 101109968 was registered on 17 Jun 2025. was recorded as a recent event.

  • Balance Sheet

    Avrohn Pharma (I) Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I. was recorded as a recent event.

  • Charges

    The activity A charge with Canara Bank amounted to Rs. 2.93 M with Charge ID 101064316 was registered on 11 Mar 2025. was completed.

  • Charges

    The activity A charge registered on 28 Sep 2022 via Charge ID 100676073 with Hdfc Bank Limited was fully satisfied on 24 Sep 2024. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Avrohn Pharma (I) Limited?

The CIN of Avrohn Pharma (I) Limited is U24119DL2012PLC232680.

Where is Avrohn Pharma (I) Limited headquartered?

Avrohn Pharma (I) Limited is headquartered at G-216, Hall No. 1, Ground Floor, Dakka Village, Near Kingsway Camp,, Delhi, Delhi, 110009.

When was Avrohn Pharma (I) Limited incorporated?

Avrohn Pharma (I) Limited was incorporated on 12 March 2012.

Who are the current directors of Avrohn Pharma (I) Limited?

The current directors of Avrohn Pharma (I) Limited are

What is the primary industry of Avrohn Pharma (I) Limited?

The primary industry of Avrohn Pharma (I) Limited is Trade.

Is Avrohn Pharma (I) Limited a listed company?

Avrohn Pharma (I) Limited is unlisted.

What is the capital structure of Avrohn Pharma (I) Limited?

The authorized capital of Avrohn Pharma (I) Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.

What is the compliance status of Avrohn Pharma (I) Limited?

The compliance status of Avrohn Pharma (I) Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available